<DOC>
	<DOCNO>NCT02299609</DOCNO>
	<brief_summary>Successfully perfuse STEMI patient receive routine transthoracic echocardiography qid 4 day placebo . Myocardial function infarct size evaluate 3 6 month .</brief_summary>
	<brief_title>Ultrasound Beams Adjunct Reperfusion Therapy STEMI</brief_title>
	<detailed_description>Patients acute STEMI successfully reperfused either thrombolytic therapy primary angioplasty stenting include study . A basal routine echocardiography obtain patient reperfusion therapy . Thereafter , patient divide two group : 1.Treatment group receive transthoracic echocardiography use Philips HD11 XE ® 30 minute qid 4 day . 2 . Placebo group Philips HD11 XE ® echo transducer apply time duration chest ultrasound turned-off . Detailed leave right ventricle function well performance index stress-strain imaging obtain analyze 3 6 month .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Inclusion criterion : Patients present within 12 hour first ST elevation myocardial infarction successfully reperfused ; complete baseline echocardiographic evaluation accept participation study Exclusion criterion : Patients : With prior ST elevation myocardial infarction Patients present &gt; 12hrs Not successfully reperfused Not complete baseline ECHO evaluation , Not accept participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>C14.280.647.500</keyword>
</DOC>